About Semaglutide
            
            Class: | GLP-1 receptor agonist  
Use: | Indicated for the management of type 2 diabetes mellitus to improve glycemic control, and for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity.  
Adult dose: | Initiate at 0.25 mg once weekly for 4 weeks, then increase to 0.5 mg once weekly. After at least 4 weeks, may increase to 1 mg once weekly based on glycemic control and tolerability.  
Pediatric dose: | Safety and efficacy not established i
         
        
            
                
                
                    
                        Drug Class
                    
                    GLP-1 receptor agonist
                 
                
                
                    
                        Uses & Indications
                    
                    Indicated for the management of type 2 diabetes mellitus to improve glycemic control, and for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity.
                 
                
                
                    
                        Storage Requirements
                    
                    Store in a refrigerator (36°F to 46°F or 2°C to 8°C). Once in use, may be stored at room temperature (up to 86°F or 30°C) for up to 56 days.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Novo Nordisk A/S, DENMARK
                    
                    
                    Package Size
                    1 Prefilled Pen (3ml) + 4 Disposable NovoFine Plus Needles
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 1146.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initiate at 0.25 mg once weekly for 4 weeks, then increase to 0.5 mg once weekly. After at least 4 weeks, may increase to 1 mg once weekly based on glycemic control and tolerability.
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients under 18 years of age.
                    
                 
                
                
                    
                        Side Effects
                    
                    Nausea, vomiting, diarrhea, constipation, abdominal pain, headache, and potential risk of pancreatitis.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and hypersensitivity to semaglutide or any of its components.
         
        
        
            
                Important Warnings
            
            Risk of thyroid C-cell tumors, pancreatitis, renal impairment, and hypoglycemia when used with insulin or sulfonylureas. Not recommended for use in patients with a history of severe gastrointestinal disease.
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.